iBio, Inc. (IBIO) vs Outset Medical, Inc. (OM)
A side-by-side comparison of iBio, Inc. and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IBIO
iBio, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
OM
Outset Medical, Inc.
$4.12HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — IBIO vs OM
growth of $100 · dividends reinvested · last 6yIBIO -99.9% (-67.8%/yr)OM -99.5% (-59.4%/yr)OM compounded faster over this window
IBIO OM
IBIO vs OM: by the numbers
- •OM is the larger company ($76M vs $68M market cap).
- •Both run net losses; OM's is the smaller (-63.06% vs -33044.00% net margin).
- •OM grew revenue faster over the past five years (8.28% vs -46.91% CAGR).
Metrics side by side
Valuation
| Metric | IBIO | OM |
|---|---|---|
| P/S ratio | 681.66 | 0.65 |
| P/B ratio | 0.80 | 0.79 |
Profitability
| Metric | IBIO | OM |
|---|---|---|
| Gross margin | 100.00% | 41.76% |
| Operating margin | -35141.00% | -56.06% |
| Net margin | -33044.00% | -63.06% |
| ROE | -38.55% | -77.12% |
| ROIC | -40.22% | -33.27% |
Growth (annualized)
| Metric | IBIO | OM |
|---|---|---|
| Revenue CAGR (5Y) | -46.91% | 8.28% |
| Total return CAGR (5Y) | -70.43% | -64.47% |
Frequently asked
- Which has grown faster, IBIO or OM?
- Over the past five years, OM grew revenue faster — IBIO at a -46.91% CAGR versus OM at 8.28%.
- How have IBIO and OM total returns compared?
- Over the past 5 years, IBIO delivered -70.43% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.